Completed Public Health & Healthcare Mathematics & Statistics

EPSRC Centre for New Mathematical Sciences Capabilities for Healthcare Technologies

In plain English

AI plain-English summary

A new £133.5 billion NHS and £4.9 billion pharmaceutical R&D investment underpins a major push to put mathematics at the centre of future healthcare. The University of Liverpool is assembling a team of mathematicians, statisticians, clinicians, and industrial partners to build the mathematical tools that personalised medicine and preventative care will require. Current models of how cells interact, how drugs penetrate tissues, and how antibiotic resistance spreads are often too simple or rely on low-quality data. This centre will use real 3D imaging data of living cells—captured at Liverpool’s Centre for Cell Imaging—to build far more accurate mathematical models. Pure mathematicians will bring in tools from hyperbolic geometry and fractional calculus to handle noisy, low-contrast medical images that defeat existing software. Statisticians will design better ways to measure how well a model matches reality. If successful, the work could improve predictions of drug toxicity for individual patients, reveal how antibiotic prescribing practices drive resistance across human networks, and produce imaging tools robust enough for routine clinical use. The centre is primarily a fundamental science investment—building the mathematical infrastructure that future medical breakthroughs will depend on, much as earlier advances in statistics and modelling made modern genomics and drug design possible.

View original technical description
As quality of life constantly improves, the average lifespan will continue to increase. Underlining this improvement is the vast amount of the UK government's support to NHS (£133.5 billion in year 2011/12) and the UK pharmaceutical industry's R&D large investment (4.9 billion to R&D in year 2011/12). The expectation of quality healthcare is inevitably high from all stakeholders. Fortunately recent advances in science and technology have enabled us to work towards personalised medicine and preventative care. This approach calls for a collective effort of researchers from a vast spectrum of specialised subjects. Advances in science and engineering is often accompanied by major development of mathematical sciences, as the latter underpin all other sciences. The UoL Centre will consist of a large and multidisciplinary team of applied and pure mathematicians, and statisticians together with healthcare researchers, clinicians and industrialists, collaborating with 15 HEIs and 40 NHS trusts plus other industrial partners and including our strongest groups: MRC Centre in Drug Safety Science, Centre for Cell imaging (CCI for live 3D and 4D imaging), Centre for Mathematical Imaging Techniques (unique in UK), Liverpool Biomedical EM unit, MRC Regenerative Medicine Hub, NIHR Health Protection Research Units, MRC Hub for Trials Methodology Research. Several research themes are highlighted below: Firstly, an improved understanding of the interaction dynamics of cells and tissues is crucial to developing effective future cures for cancer. Much of the current work is in 2D, with restrictive assumptions and without access to real data for modelling. We shall use the unparalleled real data of cell interactions in a 3D setting, generated at UoL's CCI. The real-life images obtained will have low contrast and noise and they will be analysed and enhanced by our imaging team through developing accurate and high resolution imaging models. The main imaging tools needed are segmentation methods (identifying objects such as cells and tissues regions in terms of sizes, shapes and precise boundaries). We shall propose and study a class of new 3D models, using our imaging data and analysis tools, to investigate and predict the spatial-temporal dynamics. Secondly, better models of how drugs are delivered to cells in tissues will improve personalised predictions of drug toxicity. We shall combine novel-imaging data of drug penetration into 3D experimental model systems with multi-scale mathematical models which scale-up from the level of cells to these model systems, with the ultimate aim of making better in-vitro to in-vivo predictions. Thirdly, there exist many competing models and software for imaging processing. However, for real images that have noise and are of low contrast, few methods are robust and accurate. To improve the modelling, applied and pure mathematicians team up to consider using more sophisticated tools of hyperbolic geometry and Riemann surfaces and fractional calculus to meet the demand for accuracy, and, applied mathematicians and statisticians will team up to design better data fidelity terms to model image discrepancies. Fourthly, resistance to current antibiotics means that previously treatable diseases are becoming deadly again. To understand and mitigate this, a better understanding is needed for how this resistance builds up across the human interaction networks and how it depends on antibiotic prescribing practices. To understand these scenarios, the mathematics competition in heterogeneous environments needs to be better understood. Our team links mathematical experts in analysing dynamical systems with experts in antimicrobial resistance and GPs to determine strategies that will mitigate or slow the development of anti-microbial resistance. Our research themes are aligned with, and will add value to, existing and current UoL and Research Council strategic investments, activities and future plans.

View the original record at the funder ↗

Researchers

Ahmed Elsheikh (Co-Investigator)Alexander Movchan (Co-Investigator)Anna Pratoussevitch (Co-Investigator)Bakhtier Vasiev (Co-Investigator)Francesco Falciani (Co-Investigator)Gabriela Czanner (Co-Investigator)Jonathan Read (Co-Investigator)K Chen (Principal Investigator)Kieran Sharkey (Co-Investigator)Mal Horsburgh (Co-Investigator)Marta Inmaculada Garcia-Finana (Co-Investigator)Natasha Movchan (Co-Investigator)Oleg Karpenkov (Co-Investigator)Paula Williamson (Co-Investigator)Peter Weightman (Co-Investigator)Rachel Bearon (Co-Investigator)Ruwanthi Kolamunnage-Dona (Co-Investigator)Sarah O Brien (Co-Investigator)Steve Barrett (Co-Investigator)Steven Webb (Co-Investigator)Violaine See (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

EPSRC Centre for Mathematics of Precision Healthcare
MICA: Medical Bioinformatics: Data-Driven Discovery for Personalised Medicine
Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre
EPSRC Centre for Predictive Modelling in Healthcare
BristolBridge: Bridging the Gaps between the Engineering and Physical Sciences and Antimicrobial Resistance

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.